Overview
Rogerio Lilenbaum is a Hematologist practicing medicine in New Haven, Connecticut. He has been practicing medicine for over 36 years.
Dr. Lilenbaum is highly rated in 1 condition, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer.
He is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 1 clinical trial.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
20 York St, New Haven, CT 06510
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Yale New Haven Hospital
Amer Zeidan is a Hematologist practicing medicine in New Haven, Connecticut. Dr. Zeidan is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration.
Smilow Cancer Hospital
Nikolai Podoltsev is a Hematologist practicing medicine in New Haven, Connecticut. Dr. Podoltsev is highly rated in 29 conditions, according to our data. His clinical expertise encompasses Acute Myeloid Leukemia (AML), Myeloproliferative Neoplasms (MPN), Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant.
Smilow Cancer Hospital
Scott Huntington is a Hematologist practicing medicine in New Haven, Connecticut. He has been practicing medicine for over 17 years. Dr. Huntington is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Non-Hodgkin Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
Frequently Asked Questions about Dr. Rogerio C. Lilenbaum
How do I make an appointment with Dr. Rogerio C. Lilenbaum?
You can book an appointment with Dr. Rogerio C. Lilenbaum by calling their office at 203-200-2094. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Rogerio C. Lilenbaum a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Rogerio C. Lilenbaum is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Rogerio C. Lilenbaum specialize in?
While Dr. Rogerio C. Lilenbaum is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Rogerio C. Lilenbaum participate in research or clinical trials?
Yes. Dr. Rogerio C. Lilenbaum has published 31 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Rogerio C. Lilenbaum's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Rogerio C. Lilenbaum accept my insurance?
Dr. Rogerio C. Lilenbaum accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 203-200-2094 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Lilenbaum isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.